Dr. Gretchen Marie Yandle, MD

Dr. Yandle practices at Willis Knighton Pierremont in Shreveport, Louisiana.

Dr. Yandle's NPI, 1124211099, was assigned on August 23, 2007. Dr. Yandle graduated from Louisiana State University School of Medicine in New Orleans in 2007. Dr. Yandle holds Louisiana license 202808.

Dr. Yandle's primary practice is Willis Knighton Pierremont, at 8001 Youree Dr, Shreveport, LA 71115 in Caddo Parish. The practice phone is (318) 212-3003.

Dr. Yandle's primary practice is Willis Knighton Pierremont in Shreveport, Louisiana. Dr. Yandle is also affiliated with Willis Knighton North. The medical group on file is Pulmonary & Critical Care Specialists. Dmand AI also links Dr. Yandle to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yandle practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Yandle's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Yandle is board certified in internal medicine by the American Board of Internal Medicine. Dr. Yandle is licensed in Louisiana.

CMS data shows 2,578 Medicare services from Dr. Yandle across 13 procedure codes in 2024, for 549 Medicare patients. Medicare paid $253,418 for them.

CMS counts 549 Medicare patients who saw Dr. Yandle in 2024. The largest group is 65 to 74, with 224 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yandle's median patient age at 72, with 60% women.

In 2024, Dr. Yandle wrote 853 Medicare Part D claims for 216 patients. 24% of them were for generic drugs. CMS names the drug for 774 of them, across 13 drugs with 11 or more claims each, at $668,887 in total drug cost. In 2023, CMS named 439 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Yandle for performance year 2024, reported as part of a group. Dr. Yandle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Yandle, published from 2014 to 2016. The most frequent topics are Hyperaldosteronism and Hypertension. Dr. Yandle has published most often in J La State Med Soc. Dr. Yandle's most frequent co-authors are Lee Spindler Engel, MD, Kyle Ittmann Happel, MD and Christian Carl Mabry.

CMS Open Payments shows 777 general payments to Dr. Yandle from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. GlaxoSmithKline, LLC. paid the most, $3,156.

Dr. Yandle graduated from Louisiana State University School of Medicine in New Orleans in 2007.